Avantor, Inc. (NYSE:AVTR) Receives $11.70 Consensus Price Target from Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have been assigned an average recommendation of “Hold” from the sixteen research firms that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $11.70.

Several equities research analysts recently weighed in on the company. Citigroup decreased their price target on Avantor from $13.00 to $11.00 and set a “neutral” rating for the company in a report on Thursday, February 12th. TD Cowen reissued a “hold” rating on shares of Avantor in a research note on Thursday, February 12th. Wells Fargo & Company cut their price objective on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Morgan Stanley set a $10.00 target price on shares of Avantor in a research note on Friday, February 13th. Finally, Stifel Nicolaus set a $10.00 price target on shares of Avantor in a research note on Thursday, February 12th.

Insider Buying and Selling at Avantor

In other Avantor news, Director Sanjeev K. Mehra acquired 125,000 shares of the stock in a transaction on Tuesday, March 10th. The shares were bought at an average price of $8.01 per share, with a total value of $1,001,250.00. Following the acquisition, the director owned 475,000 shares of the company’s stock, valued at $3,804,750. This trade represents a 35.71% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gregory L. Summe bought 100,000 shares of the company’s stock in a transaction on Thursday, February 12th. The shares were acquired at an average price of $9.40 per share, for a total transaction of $940,000.00. Following the transaction, the director directly owned 400,000 shares in the company, valued at $3,760,000. This trade represents a 33.33% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have acquired 275,000 shares of company stock valued at $2,399,250. 0.28% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Royal Bank of Canada boosted its position in shares of Avantor by 104.3% during the 1st quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock worth $3,302,000 after purchasing an additional 104,022 shares in the last quarter. Empowered Funds LLC increased its holdings in shares of Avantor by 40.3% in the 1st quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock valued at $286,000 after purchasing an additional 5,075 shares in the last quarter. Cetera Investment Advisers lifted its stake in shares of Avantor by 40.2% in the second quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock valued at $542,000 after purchasing an additional 11,543 shares during the period. Quantbot Technologies LP acquired a new stake in shares of Avantor in the second quarter valued at about $232,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in Avantor by 214.9% during the second quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company’s stock worth $1,670,000 after buying an additional 84,679 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

Shares of AVTR stock opened at $8.51 on Wednesday. The stock’s 50-day moving average price is $8.42 and its 200 day moving average price is $10.81. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $5.80 billion, a PE ratio of -10.91, a price-to-earnings-growth ratio of 3.34 and a beta of 1.00. Avantor has a 52-week low of $7.26 and a 52-week high of $16.17.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. The company had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.The firm’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same period last year, the firm earned $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, equities research analysts forecast that Avantor will post 1.06 EPS for the current year.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.